Page 11 - CUA guideline on the evaluation and medical management of the kidney stone patient

Kidney stone guideline update

58. Tsuji H, Umekawa T, Kurita T, et al. Analysis of bone mineral density in urolithiasis patients. Int J Urol 82. Nouvenne A, Meschi T, Prati B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-
2005;12:335-9. http://dx.doi.org/10.1111/j.1442-2042.2005.01049.x oxalate stone formers: A 3-month, randomized, controlled trial. AJCN 2010;91:565-70. http://dx.doi.
59. Tugcu V, Ozbek E, Aras B, et al. Bone mineral density measurement in patients with recurrent normocalciuric org/10.3945/ajcn.2009.28614
calcium stone disease. Urol Res 2007;35:29-34. http://dx.doi.org/10.1007/s00240-006-0074-0 83. Sorensen MD, Hsi RS, Chi T, et al. Dietary intake of fiber, fruit and vegetables decreases the risk of
60. Letavernier E, Traxer O, Daudon M, et al. Determinants of osteopenia in male renal-stone-disease patients incident kidney stones in women: A Women’s Health Initiative report. J Urol 2014;192:1694-9. http://
with idiopathic hypercalciuria. Clin J Am Soc Nephrol 2011;6:1149-54. http://dx.doi.org/10.2215/ dx.doi.org/10.1016/j.juro.2014.05.086
CJN.10191110 84. Yasui T, Okada A, Hamamoto S, et al. The association between the incidence of urolithiasis and nutrition
61. Denburg MR, Leonard MB, Haynes K, et al. Risk of fracture in urolithiasis: A population-based cohort based on Japanese National Health and Nutrition Surveys. Urolithiasis 2013;41:217-24. http://dx.doi.
study using the health improvement network. Clin J Am Soc Nephrol 2014;9:2133-40. http://dx.doi. org/10.1007/s00240-013-0567-6
org/10.2215/CJN.04340514 85. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors.
62. Elkoushy MA, Jundi M, Lee TT, et al. Bone mineral density status in urolithiasis patients with vitamin Kidney Int 2004;66:2402-10. http://dx.doi.org/10.1111/j.1523-1755.2004.66029.x
D inadequacy followed at a tertiary stone centre. Can Urol Assoc J 2014;8:323-8. http://dx.doi. 86. Baxmann AC, De OG Mendonca C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and
org/10.5489/cuaj.2055 pH in calcium stone-forming patients. Kidney Int 2003;63:1066. http://dx.doi.org/10.1046/j.1523-
63. Pasch A, Frey FJ, Eisenberger U, et al. PTH and 1.25-vitamin D response to a low-calcium diet is associated 1755.2003.00815.x
with bone mineral density in renal stone-formers. Nephrol Dial Transplant 2008;23:2563-70. http:// 87. Traxer O, Huet B, Poindexter J, et al. Effect of ascorbic acid consumption on urinary stone risk factors. J
dx.doi.org/10.1093/ndt/gfn091 Urol 2003;170:397-401. http://dx.doi.org/10.1097/01.ju.0000076001.21606.53
64. Rathod A, Bonny O, Guessous I, et al. Association of urinary calcium excretion with serum calcium and 88. Parvin M, Shakhssalim N, Basiri A, et al. The most important metabolic risk factors in recurrent urinary
vitamin D levels. Clin J Am Soc Nephrol 2015;10:452-62. http://dx.doi.org/10.2215/CJN.12511213 stone-formers. Urol J 2011;8:99-106.
65. Eisner BH, Thavaseelan S, Sheth S, et al. Relationship between serum vitamin D and 24-hour urine 89. Ohkawa M, Tokunaga S, Nakashima T, et al. Thiazide treatment for calcium urolithiasis in patients with idio-
calcium in patients with nephrolithiasis. Urology 2012;80:1007-10. http://dx.doi.org/10.1016/j. pathic hypercalciuria. Br J Urol 1992;69:571-6. http://dx.doi.org/10.1111/j.1464-410X.1992.tb15624.x
urology.2012.04.041 90. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercal -
66. Nguyen S, Baggerly L, French C, et al. 25-hydroxyvitamin D in the range of 20‒100 ng/mL and incidence of ciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med 1977;87:404-10. http://dx.doi.
kidney stones. Am J Public Health 2014;104:1783-7. http://dx.doi.org/10.2105/AJPH.2013.301368 org/10.7326/0003-4819-87-4-404
67. Hesswani C, Noureldin YA, Elkoushy MA, et al. Combined vitamin D and calcium supplementation in 91. Brocks P, Dahl C, Wolf H, et al. Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet
vitamin D inadequate patients with urolithiasis: Impact on hypercalciuria and de novo stone formation. 1981;2:124-5. http://dx.doi.org/10.1016/S0140-6736(81)90302-0
Can Urol Assoc J 2015;9:403-8. http://dx.doi.org/10.5489/cuaj.3332 92. Mortensen JT, Schultz A, Ostergaard AH. Thiazides in the prophylactic treatment of recurrent idiopathic
68. Jackson RD, LaCroix AZ, Gass M. Calcium plus vitamin D supplementation and the risk of fractures. N Engl kidney stones. Int Urol Nephrol 1986;18:265-9. http://dx.doi.org/10.1007/BF02082712
J Med 2006;354:669-83. http://dx.doi.org/10.1056/NEJMoa055218 93. Laerum S, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med
69. Penniston KL, Jones AN, Nakada SY, et al. Vitamin D repletion does not alter urinary calcium excretion Scand 1984;215:383-9. http://dx.doi.org/10.1111/j.0954-6820.1984.tb05023.x
in healthy post-menopausal women. BJU Int 2009;104:1512-6. http://dx.doi.org/10.1111/j.1464- 94. Fernandez-Rodriguez A, Arrabal-Martin M, Garcia-Ruiz MJ, et al. The role of thiazides in the prophylaxis
410X.2009.08559.x of recurrent calcium lithiasis. Actas Urol Esp 2006;30:305-9.
70. Nygaard B, Frandsen NE, Brandi L, et al. Effects of high doses of cholecalciferol in normal subjects: 95. Borghi L, Meschi T, Guerra A, et al. Randomized, prospective study of a non-thiazide diuretic, indap -
A randomized, double-blinded, placebo-controlled trial. PLoS One 2014;9:e102965. http://dx.doi. amide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 1993;22:S78-86. http://dx.doi.
org/10.1371/journal.pone.0102965 org/10.1097/00005344-199312050-00014
71. Gallagher JC, Smith LM, Yalamanchili V. Incidence of hypercalciuria and hypercalcemia during vitamin D and 96. Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but
calcium supplementation in older women. Menopause 2014;21:1173-80. http://dx.doi.org/10.1097/ magnesium hydroxide does not. J Urol 1988;139:679-84.
GME.0000000000000270 97. Nicar MJ, Peterson R, Pak CY. Use of potassium citrate as potassium supplement during thiazide therapy
72. Leaf DE, Korets R, Taylor EN, et al. Effect of vitamin D repletion on urinary calcium excretion among kidney of calcium nephrolithiasis. J Urol 1984;131:430-3.
stone-formers. Clin J Am Soc Nephrol 2012;7:829-34. http://dx.doi.org/10.2215/CJN.11331111 98. Odvina CV, Preminger GM, Lindberg JS, et al. Long-term combined treatment with thiazide and potassium
73. Haghighi A, Samimagham H, Gohardehi G. Calcium and vitamin D supplementation and risk of kidney citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int
stone formation in postmenopausal women. Iran J Kidney Dis 2013;7:210-3. 2003;63:240-7. http://dx.doi.org/10.1046/j.1523-1755.2003.00719.x
74. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in 99. Allie-Hamdulay S, Rodgers AL. Prophylactic and therapeutic properties of a sodium citrate preparation in the
idiopathic hypercalciuria. N Engl J Med 2002;346:77-84. http://dx.doi.org/10.1056/NEJMoa010369 management of calcium oxalate urolithiasis: Randomized, placebo-controlled trial. Urol Res 2005;33:116-
75. Trinchieri A, Mandressi A, Luongo P, et al. The influence of diet on urinary risk factors for stones in 24. http://dx.doi.org/10.1007/s00240-005-0466-6
healthy subjects and idiopathic renal calcium stone-formers. Br J Urol 1991;67:230-6. http://dx.doi. 100. Reddy SV, Shaik AB, Bokkisam S. Effect of potassium magnesium citrate and vitamin B-6 prophylaxis
org/10.1111/j.1464-410X.1991.tb15124.x for recurrent and multiple calcium oxalate and phosphate urolithiasis. Korean J Urol 2014;55:411-6.
76. Trinchieri A, Lizzano R, Marchesotti F, et al. Effect of potential renal acid load of foods on urinary http://dx.doi.org/10.4111/kju.2014.55.6.411
citrate excretion in calcium renal stone-formers. Urol Res 2006;34:1-7. http://dx.doi.org/10.1007/ 101. Barcelo P, Wuhl O, Servitge I, et al. Randomized, double-blind study of potassium citrate in idiopathic
s00240-005-0001-9 hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761-4.
77. Hiatt RA, Ettinger B, Caan B, et al. Randomized, controlled trial of a low-animal protein, high-fiber diet 102. Hofbauer J, Hobarth K, Szabo N, et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate
in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 1996;144:25-33. http:// urolithiasis: A prospective, randomized study. Br J Urol 1994;73:362-5. http://dx.doi.org/10.1111/
dx.doi.org/10.1093/oxfordjournals.aje.a008851 j.1464-410X.1994.tb07597.x
78. Breslau NA, Brinkley L, Hill KD, et al. Relationship of animal protein-rich diet to kidney stone forma- 103. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate — a critical review. Urol Res
tion and calcium metabolism. J Clin Endocrinol Metab 1988;66:140-6. http://dx.doi.org/10.1210/ 2005;33:73-9. http://dx.doi.org/10.1007/s00240-005-0464-8
jcem-66-1-140 104. Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against
79. Siener R, Hesse A. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2069-73. http://dx.doi.org/10.1016/
acid stone formation. Eur J Nutr 2003;42:332-7. http://dx.doi.org/10.1007/s00394-003-0428-0 S0022-5347(01)68155-2
80. Tracy CR, Best S, Bagrodia A, et al. Animal protein and the risk of kidney stones: A comparative 105. Robinson MR, Leitao VA, Haleblian GE, et al. Impact of long-term potassium citrate therapy on urinary profiles
metabolic study of animal protein sources. J Urol 2014;192:137-41. http://dx.doi.org/10.1016/j. and recurrent stone formation. J Urol 2009;181:1145-50. http://dx.doi.org/10.1016/j.juro.2008.11.014
juro.2014.01.093 106. Lojanapiwat B, Tanthanuch M, Pripathanont C, et al. Alkaline citrate reduces stone recurrence and regrowth
81. Damasio PC, Amaro CR, Cunha NB, et al. The role of salt abuse on risk for hypercalciuria. Nutr J 2011;10:3. after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol 2011;37:611-6. http://
http://dx.doi.org/10.1186/1475-2891-10-3 dx.doi.org/10.1590/S1677-55382011000500007

CUAJ • November-December 2016 • Volume 10, Issues 11-12 E357